Amyloid-β assessed by florbetapir F 18 PET and 18-month cognitive decline: A multicenter study

OBJECTIVES: Florbetapir F 18 PET can image amyloid-β (Aβ) aggregates in the brains of living subjects. We prospectively evaluated the prognostic utility of detecting Aβ pathology using florbetapir PET in subjects at risk for progressive cognitive decline. METHODS: A total of 151 subjects who previou...

詳細記述

保存先:
書誌詳細
主要な著者: Murali Doraiswamy, P., Sperling, Reisa A., Coleman, R. Edward, Johnson, Keith A., Reiman, Eric M., Davis, Mat D., Grundman, Michael, Sabbagh, Marwan N., Sadowsky, Carl H., Fleisher, Adam S., Carpenter, Alan, Clark, Christopher M., Joshi, Abhinay D., Mintun, Mark A., Skovronsky, Daniel M., Pontecorvo, Michael J.
フォーマット: Artigo
言語:Inglês
出版事項: Lippincott Williams & Wilkins 2012
主題:
Articles
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC3468774/
https://ncbi.nlm.nih.gov/pubmed/22786606
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1212/WNL.0b013e3182661f74
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料